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Oculo-auriculo-vertebral spectrum (OAVS, OMIM
164 210) is a developmental disorder primarily involving
structures derived from the ﬁrst and second pharyngeal
arches during embryogenesis. The phenotype is clinically
heterogeneous and is typically characterised by abnormal
development of the ear, mandible anomalies and defects
of the vertebral column. OAVS may occur as a multiple
congenital abnormality, and associated ﬁndings include
anomalies of the eye, brain, heart, kidneys and other
organs and systems. Both genetic and environmental
factors are thought to contribute to this craniofacial
condition, however, the mechanisms are still poorly
understood. Here, we present a review of the literature
on OAVS, discussing what is known about the aetiology,
candidate loci, possible mechanisms and the range of
clinical features that characterise this condition. We also
comment on some important aspects of recurrence risk
counselling to aid clinical management.
OVERVIEW OF OCULO-AURICULO-VERTEBRAL
SPECTRUM
Oculo-auriculo-vertebral spectrum (OAVS) is a dis-
order of craniofacial morphogenesis,1 2 with a
reported prevalence of up to 1/3500 births.3–6 It
includes a group of malformations primarily involv-
ing structures derived from the ﬁrst and second
pharyngeal arches, in particular the ear, mouth and
mandible.7–28 OAVS is aetiologically and pathogen-
etically heterogeneous. As a result of this, many
terms have been used to designate this complex
spectrum of anomalies, such as hemifacial microso-
mia, ﬁrst and second pharyngeal arch anomalies,
facio-auriculo-vertebral syndrome and Goldenhar
syndrome. The term OAVS has its origin from the
designation ‘oculoauriculovertebral dysplasia’, sug-
gested by Cohen et al (1989),2 who noted that
there was a signiﬁcant overlap between the differ-
ent entities described above and suggested that they
represent a phenotypic continuum.
Generally, the OAVS phenotype can range from
mild to severe. Craniofacial abnormalities include
asymmetric ear anomalies (preauricular tags and
pits, ear dysplasia, anotia, microtia) with or
without hearing loss (conductive and/or sensori-
neural); hemifacial microsomia resulting in facial
asymmetry; orofacial clefts; ocular defects (epibul-
bar dermoids, microphthalmia, coloboma of upper
eyelid); and vertebral abnormalities. Facial abnor-
malities are limited to one side in many, but not all
cases. The majority of patients have some degree of
facial asymmetry.13 When bilateral involvement is
present, most of them demonstrate asymmetric
involvement4 18 with more severe expression on
one side.1 The right side appears to be more
frequently involved.18 Other features such as
cardiac, genitourinary and cerebral malformations
have also been reported.7 Since not all patients
with OAVS present with all the common features,
microtia is accepted as the minimum criterion for
diagnosis, but microtia, facial asymmetry and epi-
bulbar dermoids/lipodermoids are considered
‘typical’ phenotypes.
OAVS usually occurs sporadically. However, seg-
regation analysis has suggested genetic transmission
in some cases.29 Reports of familial cases following
autosomal dominant30–33 or autosomal recessive
inheritance,4 34 35 as well as evidence for genetic
linkage in two families,36 37 and the presence of
OAVS features in patients with various chromo-
somal aberrations and genomic imbalances,35–67 all
suggest that OAVS has a genetic basis in some cases.
Environmental causes have also been suggested,
such as maternal diabetes during pregnancy, gesta-
tional or pre-existing vasoactive drugs, smoking
and twinning, indicating that a multifactorial aeti-
ology (environmental and genetic) also contributes
to some cases of OAVS.68–85
The OAVS clinical phenotype
The spectrum of phenotypic features in OAVS is
variable, ranging from subtle facial asymmetry with
a small skin tag in front of an otherwise normal-
appearing ear, to a complex phenotype comprising
multiple congenital abnormalities (see ﬁgure 1 and
table 1 for summary of phenotypes and their preva-
lence in 158 published cases7–10). Due to the vari-
able expressivity, there is no consensus regarding
the minimum diagnostic criteria for OAVS. Tasse
et al7 suggested either isolated microtia or hemifa-
cial microsomia together with mild ear malforma-
tions, such as preauricular tags and hillocks,
(suggested to be variants of microtia) as minimal
diagnostic criteria. From our clinical experience of
the condition and evidence from the literature, we
suggest that the presence of isolated hemifacial
microsomia associated with a family history of
OAVS should also be considered to be diagnostic.
Nearly all patients with OAVS have some degree
of hemifacial microsomia, resulting from maxillary
and/or mandibular hypoplasia (see summary of
phenotypes in table 1). External ear abnormalities
are also very common and include microtia, anotia,
aural atresia, preauricular tags or hillocks and pre-
auricular pits. Most affected individuals have some
degree of hearing loss, therefore, all patients with
OAVS need to have an audiological evaluation.
Facial clefts, or cleft lip and/or palate may be
observed, but these are not common features; but
macrostomia is frequently seen. The craniofacial
involvement is most commonly unilateral; but it
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can also be bilateral, usually asymmetrical. Facial palsy, asym-
metric palatal elevation, impairment of extraocular movements
and trigeminal anaesthesia have been described in OAVS.
A variety of ocular abnormalities may also be observed,
although less frequently than the name of the condition would
suggest. Epibulbar dermoids is the most common ocular ﬁnd-
ings. Microphthalmia or other severe eye malformations may
also be present but are rare. Spine deformities, impaired mobil-
ity of the spine, restricted neck movements and torticollis
should raise the suspicion of vertebral anomalies in patients
with OAVS. Moreover, congenital heart defects (tetralogy of
Fallot, septal defects, transposition of the great vessels, aortic
arch anomalies, situs inversus, dextrocardia) are not uncommon
in patients with OAVS,7–10 and screening for structural cardiac
anomalies should be part of the clinical evaluation of these
patients.
Limb (particularly radial anomalies), renal (unilateral kidney
agenesis, double ureter, renal ectopia, hydronephrosis, hydrour-
eter) and central nervous system (developmental delay, micro-
cephaly, encephalocele, hydrocephaly, hypoplasia of the corpus
callosum, Arnold–Chiari malformation, holoprosencephaly)
anomalies have also been observed in patients with OAVS.1 2 7–25
The aetiology of OAVS
Although knowledge of the genetic basis of human disease and
its effect on embryonic development has greatly expanded in
recent years, the causes of OAVS are still largely unknown, and
the involvement of both genetic and environmental factors have
been suggested.1 9 OAVS involves primarily the derivatives of
the ﬁrst and second pharyngeal arches, so it has been proposed
that the aetiology and mechanisms of OAVS are related to the
development of these structures. The pharyngeal arches, which
start to develop in the 4th week of embryonic development, are
composed of mesenchymal cells and give rise to various facial
structures, including skeletal, muscular and neural elements,
through a complex but poorly characterised signalling
network.26–28 The morphogenesis of the pharyngeal arch deri-
vatives depends on continuous and reciprocal tissue–tissue inter-
actions. One of the key features of craniofacial development is
the formation of cranial neural crest cells, which migrate ventro-
laterally as they populate the craniofacial regions. Disturbances
in the speciﬁcation, migration, proliferation, survival and ultim-
ate fate determination of the cranial neural crest cells have been
proposed as a possible mechanism for OAVS.26–28 The pheno-
typic characteristics of OAVS and severity of the defects prob-
ably depend on how the expression and activation of certain
developmental genes and proteins have been disrupted during
facial development.
Microtia is a common phenotype in OAVS, which may arise
as a consequence of neural crest cell defects and/or vascular dis-
ruption. This clinical feature can occur as an isolated defect or
in association with other anomalies, such as Treacher Collins
(TCOF1–3 mutations) and Branchio-oto-renal (EYA1, SIX1,
SIX5) syndromes.86 87 Although the role of these genes in exter-
nal ear development is not clearly deﬁned, it does show that
single gene defects can cause this phenotype by interfering in
Figure 1 Characteristic craniofacial features of oculo-auriculo-vertebral spectrum (OAVS). (A–B) Two girls with OAVS, showing hemifacial
microsomia and external ear defects. The ﬁrst girl presents right hemifacial microsomia and right microtia, with agenesis of the external auditory
meatus; she has no facial palsy, and her visual acuity is normal. The second girl has a left hemifacial microsomia and a displastic right ear with
preauricular tags and displaced tragus; she has no facial palsy, and her visual acuity is normal. Neither had any additional malformations. (C–F)
Different severities of microtia. The auricle is formed by a series of auricular hillocks that surround the 1st pharyngeal groove during the 6th week of
gestation. At the initial stages, the auricle is formed at the base of the neck, but as the mandible develops, the auricles migrate to their normal
anatomical position. Microtia occurs when the structures that form the auricle fail to develop normally. Several authors deﬁne four types of microtia
according to the level of severity (type I, when the external ear is small, the auricle retains most of its normal structure, including the external
auditory; type II, when the external ear is moderately anomalous, including hook-shaped, S-shaped or question mark-shaped auricle; type III, when
the external is a rudimentary soft tissue structure with no cartilage and the auricle does not have a normal appearance; and type IV, characterised
by anotia and absence of all external ear structures). Most cases of microtia may be difﬁcult to deﬁne as the different forms of microtia-anotia
follow a spectrum as opposed to tight groups as depicted in these photos. (G) normal ear.
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the genetic pathways necessary for normal development of mes-
enchymal tissues during fetal development.
Most OAVS cases are sporadic with no relevant family history.
However, a genetic predisposition has been proposed based on
growing evidence from the literature.29–34 Segregation analysis
performed in 311 members of the families of 74 probands with
OAVS provided evidence for an autosomal dominant mode of
inheritance with reduced penetrance.29 Interestingly, a positive
family history has been documented in only 2% of patients with
OAVS,30–34 however, from our clinical experience of the condi-
tion, we believe that this number is an underestimate, and it is
noteworthy that a recent report by Rooryck et al10 identiﬁed 12%
of familial cases in a cohort of 95 patients. An additional clinical
study by Rollnick et al19 has presented pedigree data on 97 cases,
44 of whom had a family history of the same or similar anomaly,
even if it was only minor OAVS manifestations (minor external ear
anomalies or preauricular tag, which might have been removed,
being the most common). The authors have reported that ﬁrst-
degree relatives were most often affected (35/433, 8%). Of 176
sibs cited, 11 (6%) were considered affected. In view of the family
segregation of these anomalies, the authors suggest a multifactorial
determination. Furthermore, the authors observe a broad pheno-
typic spectrum within families, an aspect that has also been
reported by others,17 18 and have proposed that familial inherit-
ance is more frequent than originally reported.19 The evidence, so
far, does not suggest that the familial OAVS phenotype is different
from the sporadic OAVS cases.
Additional evidence for a genetic basis for OAVS comes from the
identiﬁcation of chromosomal anomalies in patients with pheno-
typic characteristics of this spectrum (summarised in table 2). Some
of these abnormalities are recurrent. The 5p15 deletion has been
observed in several patients with OAVS features;39–41 the region
was further narrowed down to 5p15.33-pter by Ala-Mello, et al.42
Deletions of the 12p13.33 region, involving the WNT5B gene,
were observed in some but not all patients with OAVS features.44 45
Partially overlapping microduplications on 14q23.1 were identiﬁed
in two families with autosomal dominant OAVS;46 47 one of these
families included two ﬁrst-degree relatives with clinical features of
OAVS and Branchio-oto-renal syndrome; hence, the region
14q23.1 might harbour candidate genes for OAVS and additional
ﬁrst and second pharyngeal arch developmental disorders.
Anomalies in 22q have been frequently documented in patients
with OAVS, particularly the 22qter deletion,51 22q11.2 dele-
tions,52–54 the 22q11.1-q11.21 (Cat-eye) region,56 57 and a partial
22 trisomy (47,XX,+der(22)t(11;22)(q23;q11)), which duplicates
the 22q11 region.66 Chromosomal mosaicism for trisomy 2266 has
also been described, making this region a good candidate for some
cases of OAVS.
Other candidate single gene loci for OAVS have also been sug-
gested. Kelberman et al,36 reported linkage to a region of
approximately 10.7 cM on chromosome 14q32 (D14S987 and
Table 1 Comparison of the prevalence of phenotypes from 158
published cases (7–10). (A) Summary of phenotype prevalence rates
from 19 reports published between 1983 and 1996 as described by
Cousley & Calvert, 1997,8 and adapted by Heike & Hing, 2009.9
(B) Clinical evaluation of 53 patients7; (C) Analysis of a cohort of 86
patients10
Principal anomalies Study A (%)8 9 Study B (%)7 Study C (%)10
Head and face*
Hemifacial microsomia† – 83 84
Macrocephaly – – 5
Microcephaly – 8 –




Facial nerve palsy 10–45 –
Ear
Anotia or microtia† 66–99 100‡ 70
Preauricular tags† 34–61 67
Preauricular sinus/pit 6–9 7
Hearing loss 50–66§ 85 68
Ocular




Microphthalmia – 10 12







Vertebral anomalies 16–60¶ 53 35
Congenital heart defects 4–33 15 27
Anomalies of extremities 3–21 12 –




Urogenital anomalies 4–15 18 7‡‡




*Mandibular, malar, maxillary, or facial muscular hypoplasia.
†Minimal diagnostic criteria for OAVS.
‡Described as microtia/preauricular tag.
§Conductive hearing loss.
¶Vertebral/rib.




Table 2 Published chromosomal anomalies in patients with
phenotypic characteristics of OAVS
Chromosomal abnormality Reference
Deletion in 1p22.2–p31.1 35
Deletion 5q13.2 37
Deletion 5p15 (5p15.33–pter) 39 40 41 42
Duplication 10p14–p15 43
Deletion in 12p13.33 44 45





Deletions 22q11.2 52 53 54
Trisomy 22 55
Duplication 22q11.1–q11.21 56 57
Partial 22 trisomy of the 22q11 region 58




Mosaicism of trisomy 7 65
Mosaicism of trisomy 9 66 67
Mosaicism of trisomy 22 66
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Table 3 aCGH CNV loci reported in patients with OAVS
Dosage anomaly
(reference) Sequence coordinates Phenotype Genes in interval
Minimum
size (kb) Inheritance Array CGH platform
Del 1p22.2–p31.135 Distance from pter Mb band
74–89.5
Craniofacial dysmorphism: facial asymmetry, R epibulbar
dermoid cyst, downslanting palpebral fissures, long nose,
small mouth, high arched palate, and teeth abnormalities;
narrow ears.
Additional anomalies: Psychomotor delay; short stature;
hypermetropia; conductive hearing loss; short neck,
scoliosis; cryptorchidism.
FPGT, CRYZ, ACADM, RABGGTB, MSH4, ST6GALNAC3,
ST6GALNAC6, PIGK, AK5, FUBP1, PTGFR, IFI44,
LPHN2, PRKACB, DNASE2B, GNG5, CTBS, SSX2IP,
EDG7, MCOLN2, MCOLN3, BCL10, DDAHI, CYR61,
COL24A1, CLCA1/ CLCA2/ CLCA3, SH3GLB1, SEP15,
HS2ST1, LMO4, PKN2, GTF2B,KAT3, GBP1/ GBP2,
GBP3
15 600 n/a High-resolution karyotype
and FISH + Genosensor
Array 300 aCGH
Del 2p11.210 87 552 703–89 275 144 Craniofacial dysmorphism: L mandibular hypoplasia, cleft
palate, micrognathia; L microtia, R preauricular tags, L
pits.
Additional anomalies: not described
RGPD2, PLGLB1, PLGLB2, KRCC1, SMYD1, FABP1,
THNSL2, C2orf51, EIF2AK3, RPIA
1722 F (P) 105 K Agilent Technologies
Del 2q1110 99 119 770–99 167 676 Craniofacial dysmorphism: maxillary and facial
musculature hypoplasia, mandibular hypoplasia, L
preauricular tags, L epibulbar dermoids.
Additional anomalies: not described
TSGA10, C2orf15, LIPT1, MITD1, MRPL30 48 F (M) 44 K Agilent Technologies
Dup
4q35.113q13.110
186 295 254–86 317 114
79 675 676–81 318 868
Craniofacial dysmorphism: L mandibular hypoplasia, B
preauricular tags, R pit, R epibulbar dermoids.
Additional anomalies: IUGR; agenesis of the 12th rib pair.
SLC25A4, KIAA1 430, SPRY2 221 643 n/a 105 K Agilent Technologies
Del 5
(pter→p15.33)42
(45, XX, inv(2) (q32q37)mat,
dic(5;21) (p15.3;q22.3)dn)
Craniofacial dysmorphism: upslanting palpebral fissures,
hypertelorism, epicanthi, epibulbar dermoids, broad nose;
‘asymmetric macrostomia’ with L hemifacial microsomia
and cleft-like extension of the L corner of mouth; L cleft of
upper lip, submucous cleft palate and two preauricular
tags on L; normal ears.
Additional anomalies: language delay; IUGR, short stature;
recurrent middle ear infections; hypernasal voice; severe
myelodysplasia; history of neonatal trombocytopenia.
PLEKHG4B, CCDC127, SDHA, PDCD6, AHRR, C5orf55,
EXOC3, SLC9A3, CTD-2228K2.7, CEP72, TPPP,
ZDHHC11, BRD9, TRIP13, NKD2, SLC12A7, SLC6A19,
SLC6A18, TERT, CLPTM1 L, SLC6A3, LPCAT1, MRPL36,
NDUFS6, IRX4, IRX2 (the smallest 5p deletion
associated to OAVS features)
2000 S 44 K and 244 K Agilent
Technologies
Dup 8q11.2310 53 635 269–53 719 594 Craniofacial dysmorphism: B preauricular tags, L epibulbar
dermoids.
Additional anomalies: not described
FAM150A, RB1CC1 84 F (M) 105 K Agilent Technologies
Dup 9q34.1110 130 591 031–130 822 006 Craniofacial dysmorphism: high arched palate, B hearing
loss, B mandibular hypoplasia.
Additional anomalies: block vertebrae C3C4
TBC1D13, ENDOG, C9orf114, LRRC8A, PHYHD1,
CCBL1, DOLK, NUP188, SH3GLB2
230 F (P) 105 K Agilent Technologies
Dup 11q2110 95 725 560–95 766 136 Craniofacial dysmorphism: R epibulbar dermoids, L
mandibular hypoplasia, L microtia with preauricular tags.
Additional anomalies: not described
CCD82, JRKL 41 F (P) 44 K Agilent Technologies
Del 12p13.3310 0–2 309 191 Craniofacial dysmorphism: L mandibular hypoplasia, wide
L corner of the mouth, L microtia, preauricular tags and
pits.
Additional anomalies: learning difficulties, IUGR, patent
foramen ovale, short QT
IQSEC3, SLC6A12, SLC6A13, JARID1A, CCDC77,
B4GALNT3, NINJ2, WNK1, HSN2, RAD52, ERC1,
FBXL14, WNT5B, ADIPOR2, CACNA2D4, LRTM2,
DCP1B, CACNA1C

























(reference) Sequence coordinates Phenotype Genes in interval
Minimum




(73.9 Mb, 1p31.1) and RP5–
908D6 (89.5 Mb, 1p22.2)
Craniofacial dysmorphism: mild hypertelorism, broad nasal
tip, thin upper lip, wide L corner of the mouth, and L
hemifacial microsomia with L mandibular and condylar
hypoplasia; wide-spaced teeth; gingival hypertrophy;
bilateral dysplastic low-set ears with over-folded helix, L
microtia, L preauricular tag and pit.
Additional anomalies: delayed psychomotor development;
axial hypotonia and peripheral hypertonia; lumbar
kyphosis; patent foramen ovale; moderate L conductive
hearing loss. MRI showed L temporal arachnoid cyst with
widened subarachnoid spaces. History of IUGR and
polyhydramnios.
IQSEC3, SLC6A12, SLC6A13, JARID1A, CCDC77,
B4GALNT3, NINJ2, WNK1, HSN2, RAD52, ERC1,
FBXL14, WNT5B*, ADIPOR2, CACNA2D4, LRTM2,
DCP1B, CACNA1C
(*highlighted by the authors as candidate gene.)
2300 S 44 K Agilent Technologies
Dup 14q23.146 56 278 628–57 623 179 Craniofacial dysmorphism: defects on aural, oral,
mandibular and vertebral development.
Additional anomalies: cardiac, pulmonary, renal, skeletal
and CNS anomalies.
AK024921, BC041486,C14orf105, C14orf37,
LOC145407, EX9OC5, SEC10, MUDENG, NAT12 ,
OTX2*, SLC35F4 (*In common with47)
1034 AD qChip-Post; qGenomics SL)
Dup 14q22.3–
q23.347
14q22.3 at ∼55.774 Mb to
14q23.3 at ∼67.571 Mb
Craniofacial dysmorphism: short palpebral fissures an
lacrimal duct stenosis, bilateral facial clefts; short nose
with broad nasal bridge; micrognathia with severe
hypoplasia of mandible, high arched palate; multiple skin
tags and pits in preauricular and cheek regions; low-set
ears with abnormal antihelix and ear lobe L ear;
Eustachian tube dysfunction; adhesive otitis media.
Additional anomalies: IUGR; failure to thrive; short neck
with fusion of the pedicles and laminae on the L at C2–4;
hearing loss; torticollis; anterior ventricular septal defect;
5 cm meningocele and thin corpus callosum on MRI; deep
sacral dimple associated with conus tip at L3 with mild
thickening and fatty infiltration of the filum terminale;
small kidneys; hypoplastic genitalia.
OTX2*, PSMA3, DAAM1, RTN1, SIX6*, SIX1*, SIX4,
MNAT1, PRKCH, HIF1A, KCNH5, PPP2R5E, SYNE2,
ESR2, ZNF46, HSPA2, SPTB, GPX2, FNTB, MAX, FUT8,
MPP5, PIGH, ARG2, RDH11, RDH12 (* SIX1 gene is
disease causing BOR and located at 14q23.1)




79 617 936–87 566 775 Unilateral right-sided microtia, mild facial asymmetry; (CT)
scan unilateral aplasia of the middle cranial fossa floor on
the right, with a narrow external auditory duct; growth
retardation; no vertebral anomalies. Mother showed a
preauricular tag on R and hypothyroidism.
DIO2, TSHR, GTF2AI, STON2, SELIL, FLRT2, GALC
(adjacent to GSC locus)




Del 14q32.210 98 250 689—98 253 385 Craniofacial dysmorphism: retrognathism; high arched
palate; B anotia, B mandibular hypoplasia (R>L).
Additional anomalies: not described
C14orf177 2.7 F (M) 105 K Agilent Technologies
Del 15q24.1q24.249 **74 419 546–75 931 476 Craniofacial dysmorphism: cleft of the soft palate,
hemifacial microsomia due to malar and mandibular
hypoplasia, R grade IV microtia.
Additional anomalies: moderate psychomotor delay and
learning difficulties, growth retardation; myopia and
strabismus; bilateral conductive hearing loss hypotonia;
acute dyspnoea episodes and recurrent respiratory
infections; gastrointestinal reflux; history of IUGR.
STRA6, CCDC5, CYP11A1, UBL7, ARID3B, CLK3,
CPLX3, GOLGA6C, GOLGA6D, SIN3A, PTPN9, MAN2C,
CSK (according to the figure 2)

























(reference) Sequence coordinates Phenotype Genes in interval
Minimum
size (kb) Inheritance Array CGH platform
Del 15q2449 **70.708–73.856 Mb to
**74 419 546–75 931 476
Craniofacial dysmorphism: round, asymmetric face, smooth
philtrum cup-shaped protruding ears.
Additional anomalies: cognitive impairment, hypotonia;
recurrent ear infections, microphallus.
STRA6, CYP11A1, SEMA7A, CSK, CPLX3, MPI, and
SIN3A (defined as the minimum critical region for the
15q24 deletion syndrome)
3148 S Chromosomal Microarray




6 932 021–8 074 805 Craniofacial dysmorphism: mandibular hypoplasia; R grade
III microtia with preauricular tag.
Additional anomalies: not described
PTPRM, LRRC30, LAMA1 1142 F (P) 244 K Agilent Technologies
Dup 20p12.210 9 971 936–10 124 896 Craniofacial dysmorphism: R microphtalmia, R hemifacial
microsomia, R microtia with preauricular tag.
Additional anomalies: learning disabilities, hemivertebrae
T1, abnormal ribs, R renal agenesis.
ANKRD5 153 F (M) 105 K Agilent Technologies
Del 22q11.21–
q11.2252
20 128 705–21 246 612
20 453 484–20 551 970
Craniofacial dysmorphism: microcephaly, bilateral cleft lip
and palate, L macrostomia, multiple bilateral preauricular
tags, and small external auditory canals;
Additional anomalies: IUGR, developmental delay, multiple
ventricular septal defects.
HIC2, LOC220686, UBE2L3, LOC150223, CCDC116,
SDF2L1, PPIL2, YPEL1, MAPK1, PPM1F, TOP3B,
VPREB1, LOC96610, SUHW2, SUHW1, PRAME
1118 S High-resolution G-banding
(∼850 band level) and
aCGH44 K array
Del 22q11.253 See N25 FISH probe
coordinates at the 22q11
D22S75 locus (Vysis)
Craniofacial dysmorphism: coloboma of upper L eyelid,
cleft palate, small mouth, asymmetric mandibular
hypoplasia, L hemifacial microsomia, bilateral preauricular
tags, microtia with aural atresia of L ear; absence of
external auditory meatus and dysgenesis of inner ear
system on L; hearing loss in L ear.
Additional anomalies: CHD (double outlet R ventricle with
valvular and infundibular pulmonary stenosis, subaortic
ventricular septal defect, and normally related great
arteries); hypocalcaemia secondary to hypoparathyroidism;
low T-lymphocyte count, normal serum immunoglobulins.
Genes located inside the 22q11.2 critical region
including TBX1 and UFD1L
22q11.2 S FISH with N25 probe
Del 22q11.253 See N25 FISH probe
coordinates at the 22q11
D22S75 locus (Vysis)
Craniofacial dysmorphism: prominent forehead with a
receding hairline, mild facial asymmetry (smaller R cheek),
asymmetric crying facies, R facial droop; R ear microtia
with preauricular tag and atresia, low-set L ear with
overfolded, thick superior helix, R internal ear anomalies
(prominent vestibule, no lateral semicircular canal).
Additional anomalies: brain MRI showed open
fronto-temporal operculum with persistent cavum septum
pellucidum, mild widening of foramen of Magendie and
cisterna magna; feeding and respiratory difficulties, severe
gastro-oesophageal reflux; R-sided hearing loss; sacral
dimple, long fingers; CHD (aberrant R subclavian artery,
patent foramen ovalis, trivial tricuspid regurgitation).
Genes located inside the 22q11.2 critical region
including TBX1 and UFD1L
22q11.2 S FISH with N25 probe
Del 22q11.253 See N25 FISH probe
coordinates at the 22q11
D22S75 locus (Vysis)
Craniofacial dysmorphism: hemifacial microsomia,
periorbital fullness, broad nasal root, bulbous nasal tip,
hypoplastic nares, submucous cleft palate, small mouth, L
microtia with aural atresia, small R ear with simple
protruding helix.
Genes located inside the 22q11.2 critical region
including TBX1 and UFD1L

























(reference) Sequence coordinates Phenotype Genes in interval
Minimum
size (kb) Inheritance Array CGH platform
Additional anomalies: developmental delay; bilateral optic
nerve hypoplasia; R ear hearing loss; tapered fingers;
butterfly vertebra at T8 and T10 and sacral dimple; CHD
(small atrial septal defect ostium secundum type).
Dysphagia, feeding difficulties and laryngomalcia.
Del 22q11.254 19 782 237–22 969 069 Craniofacial dysmorphism: epibulbar dermoid, hemifacial
microsomia, bilateral ear tags
Additional anomalies: postnatal growth restriction (note,
maternal diabetes).




**17 381 569–18 618 107 Craniofacial dysmorphism: frontal bossing, facial
asymmetry, flat nasal bridge, bilateral mandibular
hypoplasia with asymmetric retrognathia; asymetric ears
with simplified helices, preauricular ear tag on L and
larger ear tag associated with the tragal cartilage on the
R, atretic R ear canal and associated sensorineural hearing
loss.
Additional anomalies: hypotonia; branchial cleft sinus,
R-sided muscular torticollis, esotropia, bilateral
clinodactyly, tapered fingers, L lower extremity shorter
than R, sacral dimple; sparse hair,
CECR1, CECR2, CECR3, CECR5, CECR6, CECR7, GAB4,
AS1, IL17RA, ATP6V1E1, BCL2L13, BID, MIR3198–1,
MIR648, FLJ41941, PEX26, TUBA8, MICAL3, USP18,
G6T3P






20 000 000–21/22 000 000 Craniofacial dysmorphism: short stature and icrocephaly.
R-sided facial cleft; R-sided external auditory canal atresia
and bilateral conductive hearing loss; flattening of
zygoma; mandibular asymmetry; bilateral epicanthal folds;
myopia.
Additional anomalies: IQ of 77; mild lumbar lordosis.
22q11.1q11.21 dup: IL17RA, CECR1, CECR2,
SLC25A18, ATP6V1E1, BID, MICAL3, PEX26, TUBA8,
and USP18.
22q11.21q11.22 del: HIC2, RIMBP3B, RIMBP3C,
UBE2L3, SDF2L1, MIR130B, PPIL2, YPEL1, MAPK1,
TOP3B, VPREB1, PRAME, GGTLC2, and RTDR1.





2 715 688–18 073 734
19 492 239–57 432 638
Craniofacial dysmorphism: L epibulbar dermoids,
micrognathia, R mandibular and maxillary hypoplasia,
macrostomia, cleft palate, B anotia.
Additional anomalies: IUGR; block cervical vertebrae.
Y chromosome (not all genes listed) 15000
38000
S 105 K Agilent Technologies
Amplification
Xp22.3310
3 588 423–3 645 922 Craniofacial dysmorphism: R epibulbar dermoids, R
mandibular hypoplasia, R preauricular tags.
Additional anomalies: not described
PRKX 57 F (P) 105 K Agilent Technologies
Trisomy X10 Craniofacial dysmorphism: R hemifacial microsomia,
micrognathia, R microtia with preauricular tags and pits,
Additional anomalies: asymmetric legs and R breast
hypoplasia.
X chromosome (not all genes listed) X S 105 K Agilent Technologies
Genes in bold are possible candidates for the OAVS phenotype.
Genome builds: **GRcH37/hg19, all other genome loci are in NCBI36/hg18.
OAVS, Oculo-auriculo-vertebral spectrum; AD, autosomal dominant; CHD, congenital heart disease; Del, deletion; dup, duplication; F, familial; IUGR, intrauterine growth restriction; L, left; M, maternal; n/a, not available; None, no pathogenic changes;






















D14S65) containing the GSC (GOOSECOID) gene in an OAVS
family with apparent autosomal dominant inheritance.
Additionally, Gimelli et al,48 reported an interstitial
14q31.1q31.3 deletion, a region adjacent to GSC, transmitted
from a mother to her daughter, both with features of hemifacial
microsomia. Although GSC could be regarded as a candidate
gene, no mutation has been found in OAVS cases with normal
karyotypes. However, GSC is now known to be mutated in a
syndrome of short stature, auditory-canal atresia, mandibular
hypoplasia and skeletal abnormalities (SAMS syndrome).88 This
is a rare autosomal-recessive developmental disorder with a
unique skeletal phenotype which, in our view, represents a dif-
ferent entity, clinically distinct from OAVS.
In another family with ﬁve OAVS patients, potential linkage
was suggested at 15q26.2-q26.3.37 Moreover, 12 genomic rear-
rangements (4 deletions and 8 duplications) ranging from 2.7 kb
to 2.3 Mb, were found by Rooryck et al,10 by high-density
oligonucleotide array comparative genomic hybridization
(aCGH) analysis (see table 3). These included a de novo
12q13.33 deletion, which has previously been associated with
OAVS44 45; a 2q11 deletion, which was present in a proband
and his affected maternal aunt; and trisomy X in a girl OAVS.
Table 2 summarises the putative chromosomal loci for OAVS
based on the abnormalities described in this review. In spite of
growing evidence for high heritability, the molecular basis of
OAVS is still elusive and, although Mendelian inheritance is
more likely in familial cases of OAVS, sporadic cases may have
polygenic or multifactorial causes.
There is no doubt that environmental factors, such as mater-
nal diabetes during pregnancy, thalidomide, vasoactive drugs,
smoking and multiple pregnancy may also play a part in caus-
ation of this condition. One of the most favoured hypotheses is
that of vascular disruption of insufﬁciency in utero.68–71 In fact,
disruption of embryonic blood ﬂow during development, mater-
nal vasoactive medication use, diabetes and twinning are predis-
posing factors to a number of structural congenital
anomalies.72 73 Moreover, a great number of case reports on
concordant and discordant twins with OAVS suggest that there
might be an association between reproductive abnormalities,
twinning and OAVS.74–76 An excess of affected infants born
after assisted reproductive techniques and frequent twinning
among naturally conceived patients with OAVS has been
reported.75 76 Furthermore, the high frequency of sporadic
cases and the notable occurrence of discordant monozygotic
twins defy simple Mendelian inheritance.77–83 It is worthwhile
pointing out that some of these reports, in which an environ-
mental exposure was considered causative, do not all mention
whether or not the relatives were carefully evaluated in order to
exclude the effect of genetic background.
Epigenetic mechanisms may be one of the ways to explain
how genes and the environment interact to impair cranial
neural crest cell development and cause this spectrum of cra-
niofacial disorders. Both assisted reproduction and monozy-
gotic twinning may predispose to epigenetic modiﬁcation.
Studies with model organisms reveal how the identity and pat-
terning of vertebrate-speciﬁc portions of the skull are epigeneti-
cally regulated and how epigenetic dysregulation in cranial
neural crest cells induces severe skull vault defects.84 Epigenetic
factors have been suggested as a possible pathogenic mechan-
ism leading to histone acetylation-dependent imbalance of
allelic expression of the BAPX1 gene, a member of the NKX
family of homeobox-containing proteins, which play a role in
skeletal development and patterning of the middle ear, in ﬁve
patients with OAVS.85
Heterogeneity encompassing genetic, epigenetic and non-
genetic factors appears to be the most likely explanation for
OAVS. A multifactorial and complex aetiology is a possible
model to explain the occurrence of this birth defect. In support
of this hypothesis, an increased recurrence risk was observed in
families with an affected OAVS relative.17–20 The recurrence risk
in ﬁrst-degree relatives of affected individuals is estimated to be
2%–3% (as we have discussed, this is probably an underesti-
mate). It has been proposed that the presence of rare and
common genetic variation, of variable penetrance and effect,
combined with environmental factors, may affect speciﬁc tissue
interactions that occur between the cranial neural crest cells and
the endoderm, mesoderm and ectoderm, and the way they
connect during their migration in establishing the foundations
of craniofacial morphogenesis, hence affecting the risk to OAVS.
Differential diagnoses of OAVS
Some patients with OAVS have clinical ﬁndings that overlap
with other syndromes involving structures derived from the ﬁrst
and second pharyngeal arches. We highlight ﬁve syndromes with
known causative genes in table 4: Treacher Collins syndrome,86
Townes–Brocks syndrome,89 CHARGE syndrome,90
Branchio-oto-renal spectrum disorders,91 and the phenotypic
spectrum associated with mutations in EFTUD2.92 93 Our view
is that these conditions are distinctive and recognisable pheno-
typic entities. The presence of anal anomalies, for instance,
points strongly towards Townes–Brock syndrome; the shape of
the ear and semicircular canal abnormality in CHARGE syn-
drome are very characteristic, and individuals with EFTUD2
mutations have microcephaly and may also have associated
oesophageal atresia. However, if features are sufﬁciently suggest-
ive, molecular testing of the genes that cause these syndromes
might be considered in some OAVS cases.
RECOMMENDATIONS FOR GENETIC COUNSELLING
The diagnosis of OAVS is frequently based only on clinical phe-
notyping, since no speciﬁc genetic tests are available and chromo-
some abnormalities have been identiﬁed in only a few cases. The
lack of consensus regarding the minimum clinical diagnostic cri-
teria for OAVS and the uncertainties regarding its aetiology cause
difﬁculties in genetic counselling. An empiric sibling recurrence
risk of 2%–3% is given in the case of a proband with OAVS, with
normal chromosomes and no family history. However, one must
be aware of occasional autosomal dominant or autosomal reces-
sive inheritance observed in some cases. Before counselling these
families, parents and siblings must be observed and the family
history ascertainment must be thorough. The identiﬁcation of
subtle clinical manifestations of OAVS in relatives is important
for recurrence risk counselling. A three-generation family history
proﬁle speciﬁcally enquiring about other relatives with facial
asymmetry, ear tags, ear pits, hearing loss, vertebral malforma-
tions, eye abnormalities, cardiac or urogenital malformations
and/or abnormalities of the extremities is essential.
If an individual with OAVS is found to have an inherited or
de novo chromosome abnormality, genetic counselling for that
condition is advised, although because of phenotypic heterogen-
eity, one cannot accurately predict the severity of OAVS should
it occur in another child with the same chromosomal disorder.
To illustrate this, we can take into account the phenotypic vari-
ability in genomic disorders such as those on 22q11 (Cat-eye
syndrome, der(22) syndrome and velocardiofacial syndrome/
DiGeorge syndrome), where chromosomal rearrangements lead
to abnormal gene dosage, resulting in phenotypes including
intellectual disability and congenital malformations.94–99
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Therefore, although no speciﬁc genetic test is currently avail-
able, aCGH screening should be considered in patients with
OAVS when recurrence risk counselling is sought, particularly in
those with multiple anomalies and/or developmental delay.
Prenatal diagnosis of sporadic cases has been seldom reported
and when achieved, has typically been in those with severe mal-
formations, but with the advent of more detailed 3D scans,
milder cases may be detectable (reviewed in Ref 9). Fetal ultra-
sound examination to detect microtia, preauricular tags and/or
asymmetric mandibular hypoplasia is possible. However, since
the genetic causes of OAVS have not been identiﬁed, prenatal
diagnosis using genetic testing is not yet possible.
Understanding the molecular basis of these malformations
will contribute to the identiﬁcation of critical genes for craniofa-
cial development and the identiﬁcation of causative gene(s) will
provide tools for diagnosis and genetic counselling of this
complex disorder.
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